{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/MNA/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MNA\",,,,,undefined,":{"symbol":"MNA","market":"US","secType":"STK","nameCN":"NYLIM Merger Arbitrage ETF","latestPrice":36.747,"timestamp":1789588800000,"preClose":36.7972,"halted":0,"volume":17073,"hourTrading":{"tag":"盘后","latestPrice":36.747,"preClose":36.747,"latestTime":"16:15 EDT","volume":9,"amount":330.72902999999997,"timestamp":1789589700197,"change":0,"changeRate":0,"amplitude":0.000082},"delay":0,"changeRate":-0.0013642342352134591,"floatShares":7100000,"shares":7100000,"eps":0,"marketStatus":"Post-Mkt","change":-0.0502,"latestTime":"09-16 17:53:15 EDT","open":36.87,"high":36.87,"low":36.69,"amount":627626,"amplitude":0.004892,"askPrice":36.7,"askSize":12,"bidPrice":33.03,"bidSize":10,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":36.7972,"sharesOutstanding":6950000,"nav":36.67173,"aum":260651089.64,"bidAskSpread":0.001323,"postHourTrading":{"tag":"盘后","latestPrice":36.747,"preClose":36.747,"latestTime":"16:15 EDT","volume":9,"amount":330.72902999999997,"timestamp":1789589700197,"change":0,"changeRate":0,"amplitude":0.000082},"volumeRatio":1.094297,"impliedVol":0.2642,"impliedVolPercentile":0.8685},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MNA\",,,,,undefined,":{"symbol":"MNA","floatShares":7100000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.094297,"shares":7100000,"dividePrice":0,"high":36.87,"amplitude":0.004892,"preClose":36.7972,"low":36.69,"week52Low":35.49,"pbRate":"--","week52High":37.19,"institutionHeld":0,"latestPrice":36.747,"committee":-0.090909,"eps":0,"divideRate":0,"volume":17073,"delay":0,"ttmEps":0,"open":36.87,"prevYearClose":35.79,"prevWeekClose":36.734,"prevMonthClose":36.62,"prevQuarterClose":36.4795,"fiveDayClose":36.7,"twentyDayClose":36.82,"sixtyDayClose":36.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MNA\",params:#limit:5,,,undefined,":[{"date":"2023-12-28","symbol":"MNA","amount":0.37752,"announcedDate":"2023-12-27","type":"dividend","market":"US","newRecordDate":"2023-12-29","defaultRemindTime":1703773800000,"name":"IQ ARB Merger Arbitrage ETF","recordDate":"2024-01-05","payableDate":"2023-12-29","currency":"USD","dateTimestamp":1703739600000,"payDate":"2024-01-05"},{"market":"US","date":"2020-12-30","symbol":"MNA","amount":0.76599,"name":"IQ ARB Merger Arbitrage ETF","recordDate":"2021-01-07","payableDate":"2020-12-31","currency":"USD","type":"dividend","dateTimestamp":1609304400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MNA\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.06134,"currency":"USD"},{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-07","value":0.76599,"currency":"USD"},{"executeDate":"2023-12-28","recordDate":"2023-12-29","paymentDate":"2024-01-05","value":0.37752,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MNA\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2630395692","title":"Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill","url":"https://stock-news.laohu8.com/highlight/detail?id=2630395692","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630395692?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:30","pubTimestamp":1777289400,"startTime":"0","endTime":"0","summary":"Builds Support for Accelerated Access to SkinJect for Gorlin Syndrome patients with a Rare Autosomal Dominant DiseasePHILADELPHIA, April  27, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3281511/0/en/Medicus-Pharma-CEO-meets-with-lawmakers-on-Energy-Commerce-Committee-on-Capitol-Hill.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1169589451.USD","MDCX","BCC","BK4023","LU1169590202.USD","PD","IND","BK4104","MNA","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624305518","title":"Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset","url":"https://stock-news.laohu8.com/highlight/detail?id=2624305518","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624305518?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:30","pubTimestamp":1775043000,"startTime":"0","endTime":"0","summary":"Provides guidance on interpretation of Topline dataset and confirms focus on drug-driven efficacy in non-melanoma skin cancerPHILADELPHIA, April  01, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASD","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/01/3266511/0/en/Medicus-Pharma-Ltd-Clarifies-Positive-SkinJect-Phase-2-Dataset.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSR","BK4104","LU1169590202.USD","BK4139","BCC","BK4023","BK4215","MDCX","PD","MNA","LU1169589451.USD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622852318","title":"Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2622852318","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622852318?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:30","pubTimestamp":1774524600,"startTime":"0","endTime":"0","summary":"200g Cohort at Day 57 Dataset suggests majority of treated Lesions may Avoid Surgery as Company targets larger unmet medical need in Non-melanoma Skin CancerPHILADELPHIA, March  26, 2026 (GLOBE NEWSWI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/26/3262893/0/en/Medicus-Pharma-Business-Update-Call-to-Highlight-80-Overall-Response-Rate-ORR-in-Phase-2-SkinJect-Study-and-Agentic-AI-enabled-Drug-Development-Plan.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","CR","ORR","LU1169590202.USD","BCC","BK4567","BK4104","BK4139","LU1169589451.USD","MNA","BK4213","CSR","BK4023","BK4215","PD","AGIX","PR","BK4161","CHAT","MDCX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":103,"code":"91000000","status":"200"}]}}